EUVIMEDEUVIMED entdecken
Crossref

Drug Discovery Research for Traumatic Brain Injury Focused on Functional Molecules in Astrocytes

Shotaro Michinaga

Biological and Pharmaceutical Bulletin · 2024

DOI: 10.1248/bpb.b23-00731 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2024. Verfasst von Shotaro Michinaga. Beteiligte Einrichtung: Department of Pharmacodynamics, Meiji Pharmaceutical University. Hauptthemen laut MEDLINE: Brain Edema, Brain Injuries, Traumatic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traumatic brain injury (TBI) is severe damage to the head caused by traffic accidents, falls, and sports. Because TBI-induced disruption of the blood-brain barrier (BBB) causes brain edema and neuroinflammation, which are major causes of death or serious disabilities, protection and recovery of BBB function may be beneficial therapeutic strategies for TBI. Astrocytes are key components of BBB integrity, and astrocyte-derived bioactive factors promote and suppress BBB disruption in TBI. Therefore, the regulation of astrocyte function is essential for BBB protection. In the injured cerebrum of TBI model mice, we found that the endothelin ETB receptor, histamine H2 receptor, and transient receptor potential vanilloid 4 (TRPV4) were predominantly expressed in reactive astrocytes. We also showed that repeated administration of an ETB receptor antagonist, H2 receptor agonist, and TRPV4 antagonist alleviated BBB disruption and brain edema in a TBI mouse model. Furthermore, these drugs decreased the expression levels of astrocyte-derived factors promoting BBB disruption and increased the expression levels of astrocyte-derived protective factors in the injured cerebrum after TBI. These results suggest that the ETB receptor, H2 receptor, and TRPV4 are molecules that regulate astrocyte function, and might be attractive candidates for the development of therapeutic drugs for TBI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain EdemaBrain Injuries, TraumaticMiceAnimalsAstrocytesTRPV Cation ChannelsBlood-Brain Barrier

Stichwörter der Autor:innen

astrocyteblood–brain barrierendothelin ETB receptorhistamine H2 receptortransient receptor potential vanilloid 4traumatic brain injury

Substanzen

TRPV Cation Channels

Autor:innen und Institutionen

  • Department of Pharmacodynamics, Meiji Pharmaceutical University.

Zitieren

APA

Michinaga, S. (2024). Drug Discovery Research for Traumatic Brain Injury Focused on Functional Molecules in Astrocytes. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b23-00731

Vancouver

Michinaga S. Drug Discovery Research for Traumatic Brain Injury Focused on Functional Molecules in Astrocytes. Biological and Pharmaceutical Bulletin. 2024. doi:10.1248/bpb.b23-00731

BibTeX
@article{Michinaga2024,
  author = {Michinaga, Shotaro},
  title = {Drug Discovery Research for Traumatic Brain Injury Focused on Functional Molecules in Astrocytes},
  journal = {Biological and Pharmaceutical Bulletin},
  year = {2024},
  doi = {10.1248/bpb.b23-00731}
}
Kostenlos starten →